Real-World Data Shows Vision Decline as Copay Programs Run Dry
A new analysis has confirmed what doctors had said in a recent survey: loss of copay assistance for retina treatments can worsen vision as they switch to alternatives or delay treatment.
A real-world analysis has confirmed the negative impact on patients when they lose copay assistance for treatments for retina and macular disease.
Presented today during a session at the annual American Academy of Ophthalmology meeting, the results show that low-income patients especially are hit hardest by underfunding of copay assistance.
Niles, M.D., vitreoretinal surgeon at Buffalo Niagara Retina, the research presented today aimed to validate with real-world clinical evidence the findings of a survey done early this year by the American Society of Retina Specialists (ASRS).
That survey, presented at the ASRS meeting in August 2025, asked 455 retina specialists about how they have adapted to the underfunding of one such program, Good Days.
Author's summary: Research confirms vision decline due to copay program underfunding.
More News
- Leonardo – Shaping the Future of Global Security and Innovation
- College Football Playoff Rankings LIVE SHOW | Reveal …
- Toughest Decisions for the CFB Playoff Committee Heading into Selection Day
- Clever George Russell trick emerges after Max Verstappen ...
- 'Not fair' - Russell criticises McLaren's Abu Dhabi team order stance
- Russell assesses Mercedes’ chance of sealing P2 in Abu Dhabi
- DiCaprio says an acting career should be ‘A Marathon, Not a Sprint’
- George Russell Stuns Title Contenders to Top Decisive FP3
- Leonardo DiCaprio Steps Out With Dad and Stepmom in Rare Appearance
- George Russell: Older me can’t envy Lando Norris’ F1 title, he deserves it